Insider Trading activities of Varian Medical Systems Inc insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Varian Medical Systems Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Varian Medical Systems Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Varian Medical Systems Inc since 2005. The reporting company's ticker symbol is VAR. The reporting company's CIK number is 203527.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $641,916,956.
The total value of stock option exercises since 2005 is $312,681,581.



Table 2. Detailed insider stock purchases, sales, and option exercises of Varian Medical Systems Inc insiders (VAR) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-05-14 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 1,112 52.83 58,746
2013-05-14 Levy Richard M (Director) Sale 20,000 70.00 1,400,000
2013-05-14 Levy Richard M (Director) Option Ex 20,000 39.85 797,000
2013-05-14 Finney Elisha W (Exec VP and CFO) Sale 5,000 69.95 349,750
2013-05-14 Finney Elisha W (Exec VP and CFO) Option Ex 5,000 49.88 249,400
2013-05-13 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 640 69.03 44,176
2013-05-13 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 640 57.90 37,056
2013-04-15 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 954 69.47 66,269
2013-04-15 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 954 52.83 50,399
2013-04-15 Kuo John W (SVP, Gen Counsel and Secretary) Sale 1,111 70.00 77,770
2013-04-15 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 1,111 52.83 58,694
2013-04-11 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 640 72.15 46,177
2013-04-11 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 640 57.90 37,056
2013-04-11 Kuo John W (SVP, Gen Counsel and Secretary) Sale 606 72.00 43,632
2013-04-11 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 606 57.90 35,087
2013-04-01 Levy Richard M (Director) Sale 20,000 71.61 1,432,140
2013-04-01 Levy Richard M (Director) Option Ex 20,000 39.85 797,000
2013-04-01 Finney Elisha W (Exec VP and CFO) Sale 5,000 71.61 358,025
2013-04-01 Finney Elisha W (Exec VP and CFO) Option Ex 5,000 49.88 249,400
2013-03-26 Guertin Timothy E (Director) Sale 100,000 71.76 7,176,100
2013-03-26 Guertin Timothy E (Director) Option Ex 100,000 50.66 5,066,000
2013-03-14 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 954 73.86 70,460
2013-03-14 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 954 52.83 50,399
2013-03-14 Kuo John W (SVP, Gen Counsel and Secretary) Sale 1,111 73.86 82,057
2013-03-14 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 1,111 52.83 58,694
2013-03-14 Levy Richard M (Director) Sale 20,000 73.86 1,477,160
2013-03-14 Levy Richard M (Director) Option Ex 20,000 39.85 797,000
2013-03-11 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 641 73.43 47,071
2013-03-11 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 641 57.90 37,113
2013-03-11 Kuo John W (SVP, Gen Counsel and Secretary) Sale 605 73.43 44,425
2013-03-11 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 605 57.90 35,029
2013-03-05 Kuo John W (SVP, Gen Counsel and Secretary) Sale 606 72.00 43,632
2013-03-05 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 606 57.90 35,087
2013-03-01 Finney Elisha W (Exec VP and CFO) Sale 5,000 69.98 349,915
2013-03-01 Finney Elisha W (Exec VP and CFO) Option Ex 5,000 49.88 249,400
2013-02-22 Laret Mark R (Director) Sale 2,102 70.05 147,245
2013-02-19 Thyagarajan Venkatraman (Director) Sale 5,000 70.73 353,660
2013-02-19 Thyagarajan Venkatraman (Director) Option Ex 5,000 47.58 237,900
2013-02-19 Naumann-etienne Ruediger (Director) Sale 2,102 70.15 147,455
2013-02-14 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 953 71.06 67,715
2013-02-14 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 953 52.83 50,346
2013-02-14 Kuo John W (SVP, Gen Counsel and Secretary) Sale 1,111 71.06 78,942
2013-02-14 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 1,111 52.83 58,694
2013-02-14 Brown John Seely (Director) Option Ex 2,956 .00 0
2013-02-12 Thyagarajan Venkatraman (Director) Option Ex 2,102 .00 0
2013-02-12 Laret Mark R (Director) Option Ex 2,102 .00 0
2013-02-12 Naumann-etienne Ruediger (Director) Option Ex 2,102 .00 0
2013-02-12 Eckert R Andrew (Director) Option Ex 2,102 .00 0
2013-02-12 Brown John Seely (Director) Option Ex 2,102 .00 0
2013-02-12 Bostrom Susan L (Director) Option Ex 2,102 .00 0
2013-02-11 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 640 70.98 45,424
2013-02-11 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 640 57.90 37,056
2013-02-01 Finney Elisha W (Exec VP and CFO) Sale 5,000 71.20 355,985
2013-02-01 Finney Elisha W (Exec VP and CFO) Option Ex 5,000 49.88 249,400
2013-01-29 Verhoef Clarence R (SVP, Finance, Corp Controller) Sale 748 71.80 53,706
2013-01-28 Naumann-etienne Ruediger (Director) Sale 5,000 72.34 361,680
2013-01-28 Naumann-etienne Ruediger (Director) Option Ex 5,000 60.32 301,600
2013-01-14 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 954 73.77 70,372
2013-01-14 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 954 52.83 50,399
2013-01-14 Kuo John W (SVP, Gen Counsel and Secretary) Sale 1,111 73.79 81,980
2013-01-14 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 1,111 52.83 58,694
2013-01-11 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 641 74.50 47,757
2013-01-11 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 641 57.90 37,113
2013-01-11 Kuo John W (SVP, Gen Counsel and Secretary) Sale 605 74.50 45,073
2013-01-11 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 605 57.90 35,029
2013-01-07 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 1,208 74.00 89,392
2013-01-07 Kluge Robert H (Corp SVP; Pres. X-Ray Products) Sale 52,834 74.50 3,936,133
2013-01-07 Kluge Robert H (Corp SVP; Pres. X-Ray Products) Option Ex 52,834 45.00 2,377,530
2013-01-07 Finney Elisha W (Exec VP and CFO) Sale 5,000 74.95 374,750
2013-01-07 Finney Elisha W (Exec VP and CFO) Option Ex 5,000 49.88 249,400
2013-01-03 Kluge Robert H (Corp SVP; Pres. X-Ray Products) Sale 43,333 73.00 3,163,309
2013-01-03 Kluge Robert H (Corp SVP; Pres. X-Ray Products) Option Ex 43,333 43.91 1,902,968
2013-01-02 Finney Elisha W (Exec VP and CFO) Sale 5,000 71.57 357,849
2013-01-02 Finney Elisha W (Exec VP and CFO) Option Ex 5,000 49.88 249,400
2012-12-26 Guertin Timothy E (Director) Sale 100,000 69.97 6,997,300
2012-12-26 Guertin Timothy E (Director) Option Ex 100,000 50.66 5,066,000
2012-12-20 Guertin Timothy E (Director) Sale 16,000 71.29 1,140,672
2012-12-20 Finney Elisha W (Exec VP and CFO) Sale 7,524 71.45 537,589
2012-12-14 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 954 71.32 68,041
2012-12-14 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 954 .00 0
2012-12-14 Kuo John W (SVP, Gen Counsel and Secretary) Sale 1,111 71.23 79,133
2012-12-14 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 1,111 .00 0
2012-12-11 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 640 72.01 46,088
2012-12-11 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 640 .00 0
2012-12-11 Kuo John W (SVP, Gen Counsel and Secretary) Sale 7,872 72.00 566,784
2012-12-11 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 7,872 .00 0
2012-12-11 Kluge Robert H (Corp SVP; Pres. X-Ray Products) Sale 40,500 72.00 2,916,000
2012-12-11 Kluge Robert H (Corp SVP; Pres. X-Ray Products) Option Ex 40,500 .00 0
2012-12-07 Kuo John W (SVP, Gen Counsel and Secretary) Sale 1,111 70.00 77,770
2012-12-07 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 1,111 .00 0
2012-12-06 Kuo John W (SVP, Gen Counsel and Secretary) Sale 12,223 69.37 847,909
2012-12-06 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 12,223 .00 0
2012-11-21 Verhoef Clarence R (SVP, Finance, Corp Controller) Option Ex 1,180 .00 0
2012-11-21 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 2,337 .00 0
2012-11-21 Kuo John W (SVP, Gen Counsel and Secretary) Option Ex 2,210 .00 0
2012-11-21 Wilson Dow R (President and CEO) Option Ex 5,403 .00 0
2012-11-21 Kluge Robert H (Corp SVP; Pres. X-Ray Products) Option Ex 3,379 .00 0
2012-11-21 Guertin Timothy E (Director) Option Ex 10,138 .00 0
2012-11-21 Finney Elisha W (Exec VP and CFO) Option Ex 3,379 .00 0
2012-11-14 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 954 68.04 64,911
2012-11-14 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 954 52.83 50,399
2012-11-12 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 7,685 68.50 526,460
2012-11-12 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 7,685 57.90 444,961
2012-11-05 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 1,153 71.00 81,863
2012-11-05 Bostrom Susan L (Director) Sale 15,691 70.33 1,103,548
2012-11-05 Bostrom Susan L (Director) Option Ex 13,000 56.47 734,045
2012-11-02 Wilson Dow R (President and CEO) Sale 26,000 70.00 1,820,000
2012-11-02 Wilson Dow R (President and CEO) Option Ex 26,000 49.88 1,296,880
2012-11-02 Finney Elisha W (Exec VP and CFO) Sale 8,000 69.95 559,600
2012-11-01 Verhoef Clarence R (SVP, Finance, Corp Controller) Sale 1,992 68.65 136,756
2012-11-01 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 27,657 67.02 1,853,489
2012-11-01 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 27,657 52.83 1,461,119
2012-11-01 Laret Mark R (Director) Sale 16,000 67.04 1,072,576
2012-11-01 Laret Mark R (Director) Option Ex 16,000 49.74 795,840
2012-11-01 Wilson Dow R (President and CEO) Sale 10,000 67.02 670,170
2012-11-01 Wilson Dow R (President and CEO) Option Ex 10,000 43.52 435,250
2012-11-01 Finney Elisha W (Exec VP and CFO) Sale 9,000 67.88 610,929
2012-11-01 Finney Elisha W (Exec VP and CFO) Option Ex 8,000 37.17 297,360
2012-10-31 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 9,769 66.70 651,621
2012-10-31 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 9,009 44.89 404,414
2012-10-31 Naumann-etienne Ruediger (Director) Sale 6,000 67.36 404,171
2012-10-31 Naumann-etienne Ruediger (Director) Option Ex 5,000 52.61 263,050
2012-10-31 Guertin Timothy E (Director) Sale 100,000 66.71 6,670,600
2012-10-31 Guertin Timothy E (Director) Option Ex 100,000 50.66 5,066,000
2012-10-31 Finney Elisha W (Exec VP and CFO) Sale 32,360 66.70 2,158,509
2012-10-31 Finney Elisha W (Exec VP and CFO) Option Ex 22,667 37.17 842,532
2012-10-31 Eckert R Andrew (Director) Sale 2,691 66.72 179,554
2012-10-01 Finney Elisha W (Exec VP and CFO) Sale 4,000 60.81 243,240
2012-10-01 Finney Elisha W (Exec VP and CFO) Option Ex 4,000 37.17 148,680
2012-09-04 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Sale 1,900 64.00 121,600
2012-09-04 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 1,900 37.17 70,623
2012-09-04 Finney Elisha W (Exec VP and CFO) Sale 4,000 60.82 243,280
2012-09-04 Finney Elisha W (Exec VP and CFO) Option Ex 4,000 38.51 154,040
2012-08-23 Verhoef Clarence R (SVP, Finance, Corp Controller) Sale 1,719 58.92 101,285
2012-08-21 Brown John Seely (Director) Sale 41,866 59.94 2,509,448
2012-08-21 Brown John Seely (Director) Option Ex 41,866 44.66 1,869,903
2012-08-20 Finney Elisha W (Exec VP and CFO) Sale 4,000 59.95 239,800
2012-08-20 Finney Elisha W (Exec VP and CFO) Option Ex 4,000 39.85 159,400
2012-07-02 Finney Elisha W (Exec VP and CFO) Sale 4,000 60.06 240,252
2012-07-02 Finney Elisha W (Exec VP and CFO) Option Ex 4,000 39.85 159,400
2012-06-07 Finney Elisha W (Exec VP and CFO) Sale 4,000 60.00 240,000
2012-06-07 Finney Elisha W (Exec VP and CFO) Option Ex 4,000 39.85 159,400
2012-05-18 Kennedy Kolleen T (SVP and Pres. Oncology Sys.) Option Ex 1,908 .00 0
2012-05-18 Chen Tai-yun (SVP and Corporate Controller) Option Ex 1,482 .00 0
2012-05-18 Kuo John W (VP, Gen Counsel and Secretary) Option Ex 2,222 .00 0
2012-05-18 Wilson Dow R (EVP and COO) Option Ex 5,796 .00 0
2012-05-18 Kluge Robert H (Corp VP; Pres. X-Ray Products) Option Ex 3,704 .00 0
2012-05-18 Guertin Timothy E (President and CEO) Option Ex 11,111 .00 0
2012-05-18 Finney Elisha W (Exec VP and CFO) Option Ex 3,704 .00 0
2012-05-02 Finney Elisha W (Exec VP and CFO) Sale 6,000 64.95 389,700

Insider trading activities including stock purchases, stock sales, and option exercises of VAR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Varian Medical Systems Inc (symbol VAR, CIK number 203527) see the Securities and Exchange Commission (SEC) website.